Selank
Also known as: TP-7, Selank nasal spray, Tuftsin analog
Russian-developed anxiolytic and cognitive enhancer — anti-anxiety without sedation or dependence.
Cognitive & Nootropic
Selank
Research use only in the US. Approved in Russia. Not scheduled/controlled in US. Consult physician for anxiety treatment.
Overview
Selank is a synthetic heptapeptide analog of tuftsin, developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is approved in Russia for anxiety, asthenic conditions, and immunodeficiency. It has anxiolytic effects comparable to benzodiazepines without sedation, dependence potential, or cognitive impairment. Also demonstrates memory enhancement and nootropic properties.
Selank is a synthetic heptapeptide (seven amino acids) developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, derived from the endogenous neuropeptide tuftsin. Tuftsin is a naturally occurring tetrapeptide that plays roles in immune activation and has mild anxiolytic properties. Selank extends this framework with additional amino acid modifications that enhance CNS penetration, metabolic stability, and anxiolytic potency. It received regulatory approval in Russia for the treatment of anxiety disorders and as an anxiolytic-nootropic — a category that reflects its unusual ability to simultaneously reduce anxiety and enhance cognitive function, two effects that are usually in opposition with conventional pharmacological approaches.
The pharmacological profile that makes Selank distinctive in the anxiolytic landscape is its benzodiazepine-free mechanism. Conventional anxiolytics — benzodiazepines like diazepam and alprazolam — work by enhancing GABA-A receptor activity throughout the brain, which reduces anxiety but also produces sedation, cognitive impairment, motor disruption, and dependency with chronic use. Selank operates through a more targeted mechanism: it modulates the GABA-A system with greater selectivity, avoiding the non-selective GABAergic enhancement that causes sedation, and also enhances enkephalin metabolism (endogenous opioid neuropeptides involved in emotional regulation) and increases BDNF expression. The net effect is anxiolysis without cognitive suppression — users report feeling calmer and more focused simultaneously.
Russian clinical trials supporting Selank's approval enrolled patients with anxiety disorders and demonstrated significant reductions in anxiety symptoms (measured by standard clinical rating scales) comparable to benzodiazepine treatment, but without the sedation, cognitive impairment, or withdrawal symptoms associated with benzodiazepines. Notably, Selank showed evidence of neuroprotective and memory-enhancing effects in addition to anxiolytic activity — an effect profile not seen with GABAergic anxiolytics. The absence of tolerance development in the published trials is particularly significant: unlike benzodiazepines, which require dose escalation over time as tolerance develops, Selank maintained consistent efficacy across the study duration without signs of tolerance or physical dependence.
Intranasal administration (via nasal spray) has become the preferred route for Selank because it enables rapid CNS delivery through the olfactory nerve pathway, bypassing the blood-brain barrier that limits peripheral peptide access to the brain. Onset via nasal spray is typically 15–30 minutes. Subcutaneous injection is also used for more precise dosing. The compound is generally considered to have an excellent safety profile based on the available clinical data.
Mechanism of Action
Selank modulates the expression of GABA-A receptor subunits, producing anxiolytic effects through GABAergic pathways. It also increases BDNF expression (brain-derived neurotrophic factor), modulates monoamine neurotransmitters (serotonin, dopamine), and has anti-inflammatory properties via cytokine modulation.
Use Cases
- ✓Anxiety and stress reduction
- ✓Cognitive enhancement and memory
- ✓Depression (as adjunct)
- ✓Immune system modulation
- ✓ADHD and focus improvement
Research Summary
Approved and widely prescribed in Russia. Multiple published Russian clinical trials demonstrate efficacy for generalized anxiety disorder, phobias, and asthenic conditions with excellent tolerability. Animal studies consistently show memory enhancement and anxiolytic effects without dependence.
Explain It Like I'm 5 Years Old
Sometimes a brain gets too worried, like a car alarm that keeps going off even when nothing is wrong. Selank is like a remote control that turns down that alarm — it calms your brain's worry center without making you sleepy or foggy. In fact, it actually helps you think more clearly at the same time as making you feel calmer. That's unusual because most anti-anxiety things make your brain slower, but this one doesn't.
How the Gym Bros Are Using It
The Russian anti-anxiety peptide taking over the nootropic community. Gym bros use it in two main ways: (1) Pre-competition or pre-public-speaking anxiety — a couple sprays in each nostril and within 30 minutes you're calm and focused without any of the sedation or brain fog of benzos, and without the edge of stimulants. (2) Daily low-dose use during stressful training blocks or high-pressure periods. The nasal spray route is easy and fast-acting. Zero dependence potential — one of its biggest advantages over pharmaceutical options. Also a useful tool for guys tapering off benzodiazepines.
Typical Dosing
250–3000 mcg intranasal (most common) or subcutaneous. Nasal spray allows easy dosing.
Administration
Research Chemical
Research use only in the US. Approved in Russia. Not scheduled/controlled in US. Consult physician for anxiety treatment.
